Imexpharm Corporation
Nguyen Thu Hien currently serves as the Head of Communications at Imexpharm Corporation since October 2023, while also working as the Public Relations Manager at Hoan My Medical Corporation since May 2021. Previous experience includes roles as PR Manager at Hanwha Life Viet Nam from May 2017 to May 2021, and Account Manager at Matterhorn Communications from October 2016 to April 2017. Nguyen Thu Hien's career began with positions as Senior Editor at Saigon Times from May 2014 to October 2016, as a Reporter at Thoi Bao Kinh Te Sai Gon from June 2006 to May 2014, and as a Reporter at Viet Nam News - Vietnam News Agency from January 2005 to May 2006. Educational background includes attendance at Ho Chi Minh City University of Technology & Foreign Language.
This person is not in any teams
This person is not in any offices
Imexpharm Corporation
Established in 1977 in Dong Thap Province, Vietnam, Imexpharm has consistently pursued excellence in quality as its unwavering commitment, dedicated to providing exceptional healthcare products of the highest quality, safety, and efficacy for patients and the community. Driven by a commitment to excellence, Imexpharm has, for nearly a half century, consistently invested in research and development, upgraded technology, established modern technical infrastructure, optimized production processes, and invested in human resources to ensure compliance with the most advanced world standards, including EU-GMP. Our dedication is reflected in our current ownership of three EU-GMP factories boasting a total of 11 production lines. This positions Imexpharm as the pharmaceutical manufacturer with the largest cluster of EU-GMP factories and the most EU-GMP production lines in Vietnam. In 2020, Imexpharm received investment from SK Investment, a member of the SK Group, the second-largest economic conglomerate in South Korea and listed in the Global Fortune 500. With a strong financial foundation and international management experience from SK Investment, Imexpharm will become the largest pharmaceutical manufacturing company in Vietnam, helping to meet the domestic and export market demands.